** Shares in Redcare Pharmacy RDC.DE fall around 13% after Kepler Cheuvreux cut its rating on the German online drug retailer to "hold" from "buy"
** The broker flags a "critical" risk with the switch to digital prescription system GesundheitsID in Germany from April 2026
** "Unless patients obtain and use a GesundheitsID, they will no longer be able to redeem e-prescriptions via online pharmacy apps using online Cardlink technology," it writes, referring to existing system
** It notes that with limited public awareness and no current mandate to compel GesundheitsID adoption, there is material risk that a large portion of Redcare e-prescription customers would be temporarily or permanently excluded from digital fulfilments channels
** Redcare Pharmacy's stock falls to more than one year low; it is at the bottom of Germany's mid-caps .MDAXI index and Europe-wide STOXX 600 .STOXX index
(Reporting by Tristan Veyet)
((tristan.chabba@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。